Search clinical trials for: Aes-103

Total 1431 results

Baxalta now part of Shire

Terminated

Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease

Sickle Cell Disease

United Kingdom
Baxalta now part of Shire
National Heart, Lung, and Blood Institute (NHLBI); SAIC-Frederick, Inc.; Cato... and other collaborators

Completed

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Sickle Cell Disease

United States
Colorado State University
AesRx, LLC

Completed

Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance

Hypoxia

United States
Kochi University

Completed

Effect of Preoperative Supplementation in Insulin Resistance

Liver Disease

Japan
Universidade Estadual de Londrina

Completed

The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence

Urinary Incontinence | Prostate Cancer
Universidade Estadual de Londrina

Completed

The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence

Urinary Incontinence | Prostate Cancer
California Allergy and Asthma Medical Group, Inc.

Unknown

Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.

Mild to Moderate Persistent Asthma

United States
Hospices Civils de Lyon

Unknown

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy (EPREX/LAM-ALLO)

Acute Myeloid Leukemia | Anemia

France
The University of Texas Health Science Center,...
U.S. Administration for Community Living

Completed

Connecting Seniors to Care

Dementia

United States
InQpharm Group

Completed

Benefit and Tolerability of IQP-AE-103 in Weight Loss

Obesity | Overweight

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Healthy Volunteers | Influenza Immunization

United States
Transwell Biotech Co., Ltd.

Completed

TWB-103 for Treating Lower Limb Ulcers on Patients With DM

Diabetic Foot Ulcer

Taiwan
Ablynx

Completed

Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Takeda

Active, not recruiting

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Dengue Fever

Mexico, United States
NephroCare Spain
Francesc Moreso

Unknown

Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients

Anemia

Spain
Alexion Pharmaceuticals

Terminated

A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously (CL01-T)

Mucopolysaccharidosis III, Type B (MPS IIIB) | Sanfilippo B

United Kingdom
Ablynx

Completed

Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Russian Federation, Canada, Hungary, Japan, Serbia, South Africa, Switzerland
CellabMED

Recruiting

A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)

Recurrent Malignant Glioma

Korea, Republic of
Takeda

Active, not recruiting

A Study of TAK-103 in Adult With Solid Tumors

Solid Tumors

Japan
CinPhloro Pharma, LLC

Recruiting

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Irritable Bowel Syndrome With Diarrhea

United States
Peptomyc S.L.

Terminated

Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure)

Pancreatic Cancer | Advanced Solid Tumors | CRC

Spain
Fondazione Telethon
Ospedale San Raffaele

Active, not recruiting

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome

Italy, United States
Cellestia Biotech AG

Terminated

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Breast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALL

United States, Spain, Korea, Republic of, Germany, France, Switzerland
Homology Medicines, Inc

Terminated

Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency

Phenylketonuria | Phenylketonurias | PAH Deficiency

United States
Schiffler Cancer Center

Completed

Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial

Prostatic Neoplasm

United States
Tenax Therapeutics, Inc.
Northwestern University; Medpace, Inc.

Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF (LEVEL)

Pulmonary Hypertension

United States
Perrigo CSCI
Analyze & Realize

Completed

DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese Subjects

Obesity | Overweight

Germany
Kochi University

Completed

Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life (KMS)

Hepatocellular Carcinoma | Chronic Liver Disease

Japan
Medicago

Completed

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older

Influenza

United States
Eutilex

Recruiting

A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy

Solid Tumor

Korea, Republic of
Gemini Therapeutics, Inc.

Completed

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Macular Degeneration | Retinal Degeneration | Geographic Atrophy | Dry Age-related Macular Degeneration | Retinal Disease

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

Colorectal Cancer

Japan
Michael Rippee
University of Kansas Medical Center; University of Kansas Health System

Completed

Ghrelin (OXE--103) for Acute Concussion Management

Traumatic Brain Injury | Concussion, Brain

United States
Gemini Therapeutics, Inc.

Terminated

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration

Macular Degeneration | Retinal Degeneration | Geographic Atrophy | Dry Age-related Macular Degeneration | Retinal Disease

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Eli Lilly and Company

Not yet recruiting

A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast

The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
Valneva Austria GmbH

Active, not recruiting

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)

Chikungunya Virus Infection

United States
Fondazione Telethon
Ospedale San Raffaele

Completed

Gene Therapy for Wiskott-Aldrich Syndrome (TIGET-WAS)

Wiskott-Aldrich Syndrome (WAS)

Italy
VA Office of Research and Development

Recruiting

Exercise Primed Stroke Rehabilitation

Stroke

United States
EMS

Completed

Efficacy and Safety of DEC103 in Pain Control Associated to Intrauterine Device (IUD) Insertion (DEC103)

Pain

Brazil
Transwell Biotech Co., Ltd.
A2 Healthcare Taiwan Corporation

Completed

TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds

Donor Site Complication

Japan, Taiwan
Schiffler Cancer Center
University of Washington; Theragenics

Completed

Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer

Prostate Cancer

United States
Military Hospital 103
Nguyen Truong Giang

Completed

Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors

Thymoma
PhotonMD, Inc

Completed

Modulated Light Therapy in Participants With Pattern Hair Loss

Androgenetic Alopecia

Australia
University Health Network, Toronto

Completed

The Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator

The Study Focuses on the Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse Events

Canada
Alexion Pharmaceuticals

Completed

Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)

Mucopolysaccharidosis IIIB

United States, United Kingdom, Spain
Medeor Therapeutics, Inc.

Not yet recruiting

Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

Kidney Transplant Rejection
CASI Pharmaceuticals, Inc.

Active, not recruiting

CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United Kingdom, France
EyeBiotech Ltd.

Recruiting

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (AMARONE)

Diabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (NVAMD)

United States, Argentina, Puerto Rico, United Kingdom
Istituto Clinico Humanitas

Completed

Multicenter Retrospective International Survey to Evaluate the Rate of AXIOS-related AEs in Endoscopic Transmural Drainage of Pancreatic Fluid Collections

Endoscopic Transmural Drainage of Pancreatic Fluid Collections
University of Leeds
The Leeds Teaching Hospitals NHS Trust; Sheffield Teaching Hospitals NHS Foundation... and other collaborators

Completed

ePRIME: Patient-Reported AEs in Early Phase Trials

Cancer

United Kingdom

Search clinical trials for: Aes-103

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations